Hemangioblastoma (HB) of the Central Nervous System (CNS)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Hemangioblastoma (HB) of the Central Nervous System (CNS) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2

NCT07167329

Real-World Effectiveness and Pharmacogenetics of Belzutifan in VHL Syndrome: The BELIEVE-VHL Trial

The BELIEVE-VHL Trial is a prospective real-life study designed to evaluate the therapeutic effects, benefits, and adverse effects of belzutifan, as well as the…

Brazil100 participantsStarted 2024-01-01

Treatment: Belzutifan

All recent trials (2 shown)

CompletedNot Applicable

NCT02120040

Psychosocial Consequences of the Screening of Von Hippel Lindau Diseases for Patients Operated for a hémangioblastoma of…

Von Hippel-Lindau (VHL) disease is a severe autosomal dominant genetic disorder (with almost complete penetrance) that predisposes to many tumors including some…

France42 participantsStarted 2014-05-02

Treatment: evaluation of anxiety with psychosocial scales